Financial Counselors Inc. raised its position in Stryker Co. (NYSE:SYK) by 40.6% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 20,033 shares of the medical technology company’s stock after purchasing an additional 5,781 shares during the period. Financial Counselors Inc.’s holdings in Stryker were worth $3,102,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Sawyer & Company Inc purchased a new position in Stryker in the fourth quarter valued at $125,000. Sit Investment Associates Inc. increased its holdings in Stryker by 114.3% in the fourth quarter. Sit Investment Associates Inc. now owns 825 shares of the medical technology company’s stock valued at $128,000 after buying an additional 440 shares in the last quarter. San Francisco Sentry Investment Group CA increased its holdings in Stryker by 47.8% in the third quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company’s stock valued at $143,000 after buying an additional 325 shares in the last quarter. Oak Point Wealth Management purchased a new position in Stryker in the fourth quarter valued at $145,000. Finally, Dubuque Bank & Trust Co. purchased a new position in Stryker in the fourth quarter valued at $164,000. 74.49% of the stock is owned by institutional investors.
A number of research firms have weighed in on SYK. Citigroup raised shares of Stryker from a “sell” rating to a “neutral” rating in a report on Tuesday. Morgan Stanley lifted their price objective on shares of Stryker from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Monday. Oppenheimer reaffirmed a “hold” rating and issued a $165.00 price objective on shares of Stryker in a report on Thursday, February 1st. Guggenheim reaffirmed a “buy” rating on shares of Stryker in a report on Wednesday, January 31st. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and issued a $170.00 price objective on shares of Stryker in a report on Wednesday, January 31st. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and fourteen have issued a buy rating to the company’s stock. Stryker has an average rating of “Hold” and a consensus price target of $163.80.
Shares of Stryker Co. (SYK) opened at $165.77 on Tuesday. The company has a market cap of $60,579.61, a PE ratio of 61.85, a PEG ratio of 2.32 and a beta of 0.70. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.59 and a current ratio of 2.29. Stryker Co. has a one year low of $127.19 and a one year high of $170.00.
Stryker (NYSE:SYK) last posted its quarterly earnings results on Tuesday, January 30th. The medical technology company reported $1.96 earnings per share for the quarter, topping analysts’ consensus estimates of $1.95 by $0.01. The firm had revenue of $3.47 billion for the quarter, compared to analyst estimates of $3.42 billion. Stryker had a net margin of 8.20% and a return on equity of 24.56%. Stryker’s quarterly revenue was up 9.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.78 earnings per share. research analysts forecast that Stryker Co. will post 7.12 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, April 30th. Investors of record on Thursday, March 29th will be given a dividend of $0.47 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $1.88 dividend on an annualized basis and a yield of 1.13%. Stryker’s payout ratio is presently 70.15%.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.